Mandate

Vinge advises Symphony Technology Group in connection with the public offer for IBS

May 18, 2011

Vinge advises Symphony Technology Group in connection with the public offer for IBS AB, listed on NASDAQ OMX First North. Symphony Technology Group offers SEK 1.75 in cash per share in IBS, regardless of share class, and the board of directors of IBS has unanimously recommended the shareholders to accept the offer. Shareholders representing approximately 75.5 percent of the shares and 81.4 percent of the votes have irrevocably undertaken to accept the offer.

Vinge’s team consists of partner in charge Pontus Enquist as well as Emil Hedberg. In addition, Fabian Ekeblad has advised on banking and finance issues, and Johan Mattsson, Maria Eierborg, Moa Bergsten, Mikael Satama Granberg, Per Westman and Anders Frick, among other, have participated in the due diligence carried out on IBS.

Related

Vinge has advised HealthCap on the establishment of HealthCap IX

HealthCap IX has held its final closing, raising total commitments in excess of the target from a diverse investor base comprising established institutions, pension funds, and renowned investors within the life sciences sector. The strong support reflects continued confidence in HealthCap’s strategy and proven track record.
August 22, 2025

Vinge advises MAAG Gear with its MEUR 18.5 refinancing

Vinge has advised MAAG Gear in connection with entering into a EUR 18 500 000 facility agreement with Danske Bank A/S for the purpose of, among other things, refinancing its previous credit. MAAG Gear is a leading manufacturer of industrial gear solutions for cement and mining applications with a comprehensive product portfolio and global aftermarket services offering.
August 21, 2025

Vinge has advised Direktronik in conjunction with the acquisition of Qvintus

Direktronik, a subsidiary of Lagercrantz Group, has acquired all shares in Qvintus.
August 19, 2025